ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T)
JPY 2041.0
(-0.34%)
JPY 2041.0
(-0.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.48 Billion | 3.35 Billion | 2.84 Billion | 6.54 Billion | -492 Million | 2.5 Billion |
| Net Income | 7.54 Billion | 5.35 Billion | 6.16 Billion | 2.71 Billion | 649 Million | 1.74 Billion |
| Depreciation & Amortization | 2.66 Billion | 3.12 Billion | 2.88 Billion | 3.36 Billion | 3.76 Billion | 2.61 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.2 Billion | -4.5 Billion | -3.02 Billion | -139 Million | -5.24 Billion | -2.27 Billion |
| Other non-cash items | 4.4 Billion | -631 Million | -3.18 Billion | 6.62 Billion | 15.18 Billion | 6.52 Billion |
| Investing Cash Flow | 1.7 Billion | -1.12 Billion | 6.74 Billion | -2.86 Billion | -2.92 Billion | -14.78 Billion |
| Investments in PPE | -1.45 Billion | -746 Million | -2.37 Billion | -1.1 Billion | -2.26 Billion | -15.72 Billion |
| Acquisitions | -1.46 Billion | -285 Million | -53 Million | -2.34 Billion | - | -2 Million |
| Investment purchases | -852 Million | -400 Million | -56 Million | -1 Million | -65 Million | -599 Million |
| Sales/Maturities of investments | 4.63 Billion | 190 Million | 11 Million | 599 Million | - | 1.64 Billion |
| Other Investing Activities | 845 Million | 115 Million | 9.21 Billion | -18 Million | -597 Million | -104 Million |
| Financing Cash Flow | -3.94 Billion | -1.82 Billion | -2.99 Billion | -455 Million | -392 Million | 13.03 Billion |
| Debt repayment | -3.13 Billion | -1.42 Billion | -2.29 Billion | -23 Million | -48 Million | -13.51 Billion |
| Dividends payments | -792 Million | -452 Million | -398 Million | -484 Million | -398 Million | -395 Million |
| Common Stock Repurchased | 9 Million | 55 Million | -248 Million | 52 Million | 54 Million | -2 Million |
| Common Stock Issuance | 9 Million | 1.36 Billion | 248 Million | 52 Million | 54 Million | 4 Million |
| Other Financing Activities | -22 Million | -1.36 Billion | -300 Million | -100 Million | 6 Million | -90 Million |
| Accounts receivables | -370 Million | -742 Million | -1.36 Billion | 639 Million | -8.47 Billion | -622 Million |
| Accounts payables | 1.49 Billion | -980 Million | 412 Million | 392 Million | -1.05 Billion | 1.88 Billion |
| Inventory | -2.71 Billion | -2.62 Billion | -687 Million | -330 Million | 2.21 Billion | -2.13 Billion |
| Other working capital | -4.62 Billion | -153 Million | -1.38 Billion | -840 Million | 2.06 Billion | -1.4 Billion |
| Cash at beginning of period | 17.5 Billion | 17.1 Billion | 10.51 Billion | 7.29 Billion | 11.1 Billion | 10.34 Billion |
| Cash at end of period | 16.73 Billion | 17.5 Billion | 17.1 Billion | 10.51 Billion | 7.29 Billion | 11.1 Billion |
| Capital Expenditure | -1.45 Billion | -746 Million | -2.37 Billion | -1.1 Billion | -2.26 Billion | -15.72 Billion |
| Effect of forex changes on cash | -15 Million | -2 Million | - | - | -2 Million | 1 Million |
| Net cash flow / Change in cash | -767 Million | 402 Million | 6.58 Billion | 3.22 Billion | -3.81 Billion | 761 Million |
| Free Cash Flow | 33 Million | 2.6 Billion | 465 Million | 5.43 Billion | -2.75 Billion | -13.21 Billion |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.27 Billion | 1.08 Billion | 7.54 Billion | 2.32 Billion | 2.7 Billion | 1.42 Billion |
| Depreciation & Amortization | - | - | 2.66 Billion | 715 Million | 697 Million | 679 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -6.2 Billion | - | - | - |
| Other non-cash items | -1.27 Billion | -1.08 Billion | 4.4 Billion | -2.32 Billion | -2.7 Billion | -1.42 Billion |
| Investing Cash Flow | - | - | 1.7 Billion | - | - | - |
| Investments in PPE | - | - | -1.45 Billion | - | - | - |
| Acquisitions | - | - | -1.46 Billion | - | - | - |
| Investment purchases | - | - | -852 Million | - | - | - |
| Sales/Maturities of investments | - | - | 4.63 Billion | - | - | - |
| Other Investing Activities | - | - | 845 Million | - | - | - |
| Financing Cash Flow | - | - | -3.94 Billion | - | - | - |
| Debt repayment | - | - | -3.13 Billion | - | - | - |
| Dividends payments | - | - | -792 Million | - | - | - |
| Common Stock Repurchased | - | - | 9 Million | - | - | - |
| Common Stock Issuance | - | - | 9 Million | - | - | - |
| Other Financing Activities | - | - | -22 Million | - | - | - |
| Accounts receivables | - | - | -370 Million | - | - | - |
| Accounts payables | - | - | 1.49 Billion | - | - | - |
| Inventory | - | - | -2.71 Billion | - | - | - |
| Other working capital | - | - | -4.62 Billion | - | - | - |
| Cash at beginning of period | - | - | 17.5 Billion | 19.44 Billion | 15.18 Billion | 17.5 Billion |
| Cash at end of period | - | - | 16.73 Billion | 17.45 Billion | 19.44 Billion | 15.18 Billion |
| Capital Expenditure | - | - | -1.45 Billion | - | - | - |
| Effect of forex changes on cash | - | - | -15 Million | - | - | - |
| Net cash flow / Change in cash | - | - | -767 Million | -1.99 Billion | 4.26 Billion | -2.32 Billion |
| Free Cash Flow | - | - | 33 Million | 1.43 Billion | 1.39 Billion | 1.35 Billion |
TELDF
ACGI
TRNS
DRCT
ULTJ
VGLS